BlueSphere Bio CSO Alan Korman Recipient of Esteemed 2025 William B. Coley Award
Alan Korman honored in the category of tumor immunology for foundational role in checkpoint inhibitors BlueSphere Bio, a clinical stage drug development company focused on novel T cell based therapies, today announced its Chief Scientific Officer, Alan Korman, Ph.D. is the 2025 recipient of one of the Cancer Research Insititute's (CRI) highest scientific honors, the […]